A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-10-24
DOI
10.3389/fphar.2016.00380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bridging the Gap between the Clinician and the Patient with Cryopyrin-Associated Periodic Syndromes
- (2017) L. Cantarini et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Recurrent Pericarditis: Modern Approach in 2016
- (2016) Massimo Imazio et al. Current Cardiology Reports
- The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
- (2016) Shankar Baskar et al. Cardiology Research and Practice
- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
- (2015) Giacomo Emmi et al. CLINICAL RHEUMATOLOGY
- Finding a Place for Interleukin-1 Inhibitors in the Treatment of Rheumatologic Diseases
- (2015) Donna Finch et al. CURRENT PHARMACEUTICAL DESIGN
- Canakinumab efficacy in refractory adult-onset PFAPA syndrome
- (2015) Giuseppe Lopalco et al. International Journal of Rheumatic Diseases
- Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study
- (2015) Luca Cantarini et al. International Journal of Rheumatic Diseases
- The Role of IL-1βin the Bone Loss during Rheumatic Diseases
- (2015) Piero Ruscitti et al. MEDIATORS OF INFLAMMATION
- Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
- (2015) Linda Rossi-Semerano et al. Orphanet Journal of Rare Diseases
- Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
- (2015) Giulio Cavalli et al. RHEUMATOLOGY
- Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
- (2015) Francesco La Torre et al. RHEUMATOLOGY INTERNATIONAL
- Anakinra for the treatment of acute severe gout in critically ill patients
- (2015) Jessica T. Thueringer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
- (2015) Ahmet Gül et al. ARTHRITIS RESEARCH & THERAPY
- Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study
- (2014) Antoine Néel et al. AUTOIMMUNITY REVIEWS
- Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
- (2014) Campbell Howard et al. Cardiovascular Diabetology
- Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate
- (2014) Giuseppe Lopalco et al. CLINICAL RHEUMATOLOGY
- Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab
- (2014) Roberto Scarpioni et al. CLINICAL RHEUMATOLOGY
- Anakinra treatment in patients with gout and type 2 diabetes
- (2014) Antonio Vitale et al. CLINICAL RHEUMATOLOGY
- Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
- (2014) Antonio Vitale et al. DERMATOLOGY
- Long-Term Efficacy of Interleukin-1 Receptor Antagonist (Anakinra) in Corticosteroid-Dependent and Colchicine-Resistant Recurrent Pericarditis
- (2014) Martina Finetti et al. JOURNAL OF PEDIATRICS
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab
- (2013) Maria Giuseppina Brizi et al. ANNALS OF INTERNAL MEDICINE
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- IL-1 signaling in atherosclerosis: sibling rivalry
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Targeting inflammasomes in rheumatic diseases
- (2013) Alexander So et al. Nature Reviews Rheumatology
- Role of caspase-1 in regulation of triglyceride metabolism
- (2013) M. E. Kotas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
- (2013) Roberta Caorsi et al. ARTHRITIS RESEARCH & THERAPY
- Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
- (2013) Saik Urien et al. BMC Pharmacology & Toxicology
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
- (2012) Heleen D de Koning et al. ANNALS OF THE RHEUMATIC DISEASES
- Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome
- (2012) Laura J Dickie et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes
- (2012) Monisha Banerjee et al. CLINICA CHIMICA ACTA
- Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
- (2012) D. NORDSTROM et al. JOURNAL OF RHEUMATOLOGY
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
- (2012) C. Galeotti et al. RHEUMATOLOGY
- Autoinflammatory diseases and cardiovascular manifestations
- (2011) Donato Rigante et al. ANNALS OF MEDICINE
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
- (2011) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
- (2011) C. M. Hedrich et al. RHEUMATOLOGY INTERNATIONAL
- Therapeutic responses and prognosis in adult-onset Still’s disease
- (2011) Hyoun-Ah Kim et al. RHEUMATOLOGY INTERNATIONAL
- IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
- (2010) L Naumann et al. ANNALS OF THE RHEUMATIC DISEASES
- Post-Stroke Infection: A Role for IL-1ra?
- (2010) Pat Tanzi et al. Neurocritical Care
- Hyperimmunoglobulin D Syndrome in Childhood
- (2010) Jeroen C. H. van der Hilst et al. Current Rheumatology Reports
- Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1β and IL-1 receptor antagonist in the ischemic cortex
- (2009) Jin A. Shin et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical Features and Prognosis of Adult-onset Still's Disease: 61 Cases from China
- (2009) T. ZENG et al. JOURNAL OF RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now